4.7 Article

Sex Differences in Repolarization Markers: Telemonitoring for Chronic Heart Failure Patients

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 12, Issue 14, Pages -

Publisher

MDPI
DOI: 10.3390/jcm12144714

Keywords

myocardial repolarization; Tend; sex differences; chronic heart failure telemonitoring

Ask authors/readers for more resources

This study aims to evaluate possible differences between men and women in ECG repolarization markers for the telemonitoring of CHF patients. The results show that Te-SD can be considered a risk factor for CHF worsening and complications for both female and male patients, but different cutoffs should be taken into account.
Aging and chronic heart failure (CHF) are responsible for the temporal inhomogeneity of the electrocardiogram (ECG) repolarization phase. Recently, some short period repolarization-dispersion parameters have been proposed as markers of acute decompensation and of mortality risk in CHF patients. Some important differences in repolarization between sexes are known, but their impact on ECG markers remains unstudied. The aim of this study was to evaluate possible differences between men and women in ECG repolarization markers for the telemonitoring of CHF patients. Method: 5 min ECG recordings were collected to assess the mean and standard deviation (SD) of the following variables: QT end (QTe), QT peak (QTp), and T peak to T end (Te) in 215 decompensated CHF (age range: from 49 to 103 years). Thirty-day mortality and high levels of NT-pro BNP (<75 percentile) were considered markers of decompensated CHF. Results: A total of 34 patients (16%) died during the 30-day follow-up, without differences between sexes. Women showed a more preserved ejection fraction and higher LDL and total cholesterol levels. Among female patients, implantable cardioverter devices, statins, and antiplatelet agents were less used. Data for Te mean showed increased values among deceased men and women compared to survival, but Te-SD was shown to be the most reliable marker for CHF reacutization in both sexes. Conclusion: Te-SD could be considered a risk factor for CHF worsening and complications for female and male patients, but different cut offs should be taken into account. (ClinicalTrials.gov number, NCT04127162.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available